AKY15-HK-301_NEPA Study

NCT03386617 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: NEPA

Sponsor

Chinese University of Hong Kong

Collaborators

[object Object]